292 related articles for article (PubMed ID: 33626315)
1. Epithelial and Endothelial Expressions of ACE2: SARS-CoV-2 Entry Routes.
Guney C; Akar F
J Pharm Pharm Sci; 2021; 24():84-93. PubMed ID: 33626315
[TBL] [Abstract][Full Text] [Related]
2. SARS-CoV-2 cell entry receptor ACE2 mediated endothelial dysfunction leads to vascular thrombosis in COVID-19 patients.
Kumar A; Narayan RK; Kumari C; Faiq MA; Kulandhasamy M; Kant K; Pareek V
Med Hypotheses; 2020 Dec; 145():110320. PubMed ID: 33032170
[TBL] [Abstract][Full Text] [Related]
3. Effects of endurance training on the expression of host proteins involved in SARS-CoV-2 cell entry in C57BL/6J mouse.
Tamura Y; Jee E; Kouzaki K; Kotani T; Nakazato K
Physiol Rep; 2021 Sep; 9(17):e15014. PubMed ID: 34523264
[TBL] [Abstract][Full Text] [Related]
4. Up-regulation of ACE2, the SARS-CoV-2 receptor, in asthmatics on maintenance inhaled corticosteroids.
O'Beirne SL; Salit J; Kaner RJ; Crystal RG; Strulovici-Barel Y
Respir Res; 2021 Jul; 22(1):200. PubMed ID: 34233672
[TBL] [Abstract][Full Text] [Related]
5. Extracellular vesicles containing ACE2 efficiently prevent infection by SARS-CoV-2 Spike protein-containing virus.
Cocozza F; Névo N; Piovesana E; Lahaye X; Buchrieser J; Schwartz O; Manel N; Tkach M; Théry C; Martin-Jaular L
J Extracell Vesicles; 2020 Dec; 10(2):e12050. PubMed ID: 33391636
[TBL] [Abstract][Full Text] [Related]
6. SARS-CoV-2 infects human pancreatic β cells and elicits β cell impairment.
Wu CT; Lidsky PV; Xiao Y; Lee IT; Cheng R; Nakayama T; Jiang S; Demeter J; Bevacqua RJ; Chang CA; Whitener RL; Stalder AK; Zhu B; Chen H; Goltsev Y; Tzankov A; Nayak JV; Nolan GP; Matter MS; Andino R; Jackson PK
Cell Metab; 2021 Aug; 33(8):1565-1576.e5. PubMed ID: 34081912
[TBL] [Abstract][Full Text] [Related]
7. Role of ACE2 in pregnancy and potential implications for COVID-19 susceptibility.
Azinheira Nobrega Cruz N; Stoll D; Casarini DE; Bertagnolli M
Clin Sci (Lond); 2021 Aug; 135(15):1805-1824. PubMed ID: 34338772
[TBL] [Abstract][Full Text] [Related]
8. Regulation of the Expression of SARS-CoV-2 Receptor Angiotensin-Converting Enzyme 2 in Nasal Mucosa.
Takabayashi T; Yoshida K; Imoto Y; Schleimer RP; Fujieda S
Am J Rhinol Allergy; 2022 Jan; 36(1):115-122. PubMed ID: 34232770
[TBL] [Abstract][Full Text] [Related]
9. Expression of SARS-CoV-2 entry factors, electrolyte, and mineral transporters in different mouse intestinal epithelial cell types.
Pearce SC; Suntornsaratoon P; Kishida K; Al-Jawadi A; Guardia J; Nadler I; Flores J; Shiarella R; Auvinen M; Yu S; Gao N; Ferraris RP
Physiol Rep; 2021 Nov; 9(21):e15061. PubMed ID: 34755492
[TBL] [Abstract][Full Text] [Related]
10. SNX27 suppresses SARS-CoV-2 infection by inhibiting viral lysosome/late endosome entry.
Yang B; Jia Y; Meng Y; Xue Y; Liu K; Li Y; Liu S; Li X; Cui K; Shang L; Cheng T; Zhang Z; Hou Y; Yang X; Yan H; Duan L; Tong Z; Wu C; Liu Z; Gao S; Zhuo S; Huang W; Gao GF; Qi J; Shang G
Proc Natl Acad Sci U S A; 2022 Jan; 119(4):. PubMed ID: 35022217
[TBL] [Abstract][Full Text] [Related]
11. Can cilia provide an entry gateway for SARS-CoV-2 to human ciliated cells?
Buqaileh R; Saternos H; Ley S; Aranda A; Forero K; AbouAlaiwi WA
Physiol Genomics; 2021 Jun; 53(6):249-258. PubMed ID: 33855870
[TBL] [Abstract][Full Text] [Related]
12. Mechanics Insights of Alpha-Lipoic Acid against Cardiovascular Diseases during COVID-19 Infection.
Rochette L; Ghibu S
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360751
[TBL] [Abstract][Full Text] [Related]
13. SARS-CoV-2 tropism to intestinal but not gastric epithelial cells is defined by limited ACE2 expression.
Paužuolis M; Fatykhova D; Zühlke B; Schwecke T; Neyazi M; Samperio-Ventayol P; Aguilar C; Schlegel N; Dökel S; Ralser M; Hocke A; Krempl C; Bartfeld S
Stem Cell Reports; 2024 May; 19(5):629-638. PubMed ID: 38670110
[TBL] [Abstract][Full Text] [Related]
14. Unraveling the Role of ACE2, the Binding Receptor for SARS-CoV-2, in Inflammatory Bowel Disease.
Ferreira-Duarte M; Estevinho MM; Duarte-Araújo M; Magro F; Morato M
Inflamm Bowel Dis; 2020 Nov; 26(12):1787-1795. PubMed ID: 33064147
[TBL] [Abstract][Full Text] [Related]
15. SARS-CoV-2 induced vascular endothelial dysfunction: direct or indirect effects?
Lui KO; Ma Z; Dimmeler S
Cardiovasc Res; 2024 Feb; 120(1):34-43. PubMed ID: 38159046
[TBL] [Abstract][Full Text] [Related]
16. B
Stevens BR; Ellory JC; Preston RL
Function (Oxf); 2021; 2(4):zqab027. PubMed ID: 34847569
[TBL] [Abstract][Full Text] [Related]
17. Revealing Tissue-Specific SARS-CoV-2 Infection and Host Responses using Human Stem Cell-Derived Lung and Cerebral Organoids.
Tiwari SK; Wang S; Smith D; Carlin AF; Rana TM
Stem Cell Reports; 2021 Mar; 16(3):437-445. PubMed ID: 33631122
[TBL] [Abstract][Full Text] [Related]
18. The use of human iPSC-derived alveolar organoids to explore SARS-CoV-2 variant infections and host responses.
Gandikota C; Vaddadi K; Sivasami P; Huang C; Liang Y; Pushparaj S; Deng X; Channappanava R; Metcalf JP; Liu L
J Med Virol; 2024 Apr; 96(4):e29579. PubMed ID: 38572923
[TBL] [Abstract][Full Text] [Related]
19. Cardiorenal Tissues Express SARS-CoV-2 Entry Genes and Basigin (BSG/CD147) Increases With Age in Endothelial Cells.
Ahmetaj-Shala B; Vaja R; Atanur SS; George PM; Kirkby NS; Mitchell JA
JACC Basic Transl Sci; 2020 Nov; 5(11):1111-1123. PubMed ID: 33073064
[TBL] [Abstract][Full Text] [Related]
20. Modulations of Homeostatic ACE2, CD147, GRP78 Pathways Correlate with Vascular and Endothelial Performance Markers during Pulmonary SARS-CoV-2 Infection.
Nisa A; Kumar R; Ramasamy S; Kolloli A; Olejnik J; Jalloh S; Gummuluru S; Subbian S; Bushkin Y
Cells; 2024 Feb; 13(5):. PubMed ID: 38474396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
